Latest Sublicensing Agreements News

Page 1 of 1

Botanix’s ECCLOCK® Gel Gains South Korean Approval, Launch Set for 2026

Botanix Pharmaceuticals’ ECCLOCK® gel, a treatment for excessive sweating, has secured regulatory approval in South Korea, paving the way for a commercial launch in early 2026.

Ada Torres

5 Sept 2025

Top